IBDEI088 ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10876,1,2,0)
 ;;=2^Destroy Ext Retinopathy, one/more sessions
 ;;^UTILITY(U,$J,358.3,10876,1,3,0)
 ;;=3^67228
 ;;^UTILITY(U,$J,358.3,10877,0)
 ;;=67220^^54^610^1^^^^1
 ;;^UTILITY(U,$J,358.3,10877,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10877,1,2,0)
 ;;=2^Destroy Choroid Lesion, one/more sessions
 ;;^UTILITY(U,$J,358.3,10877,1,3,0)
 ;;=3^67220
 ;;^UTILITY(U,$J,358.3,10878,0)
 ;;=67221^^54^610^6^^^^1
 ;;^UTILITY(U,$J,358.3,10878,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10878,1,2,0)
 ;;=2^Photodynamic Therapy, one/more sessions
 ;;^UTILITY(U,$J,358.3,10878,1,3,0)
 ;;=3^67221
 ;;^UTILITY(U,$J,358.3,10879,0)
 ;;=67225^^54^610^7^^^^1
 ;;^UTILITY(U,$J,358.3,10879,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10879,1,2,0)
 ;;=2^Photodynamic Tx,2nd eye/1 session
 ;;^UTILITY(U,$J,358.3,10879,1,3,0)
 ;;=3^67225
 ;;^UTILITY(U,$J,358.3,10880,0)
 ;;=66821^^54^610^12^^^^1
 ;;^UTILITY(U,$J,358.3,10880,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10880,1,2,0)
 ;;=2^YAG Capsulotomy
 ;;^UTILITY(U,$J,358.3,10880,1,3,0)
 ;;=3^66821
 ;;^UTILITY(U,$J,358.3,10881,0)
 ;;=92134^^54^611^2^^^^1
 ;;^UTILITY(U,$J,358.3,10881,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10881,1,2,0)
 ;;=2^CPTR Ophth Dx Img Post Segmt
 ;;^UTILITY(U,$J,358.3,10881,1,3,0)
 ;;=3^92134
 ;;^UTILITY(U,$J,358.3,10882,0)
 ;;=76512^^54^611^13^^^^1
 ;;^UTILITY(U,$J,358.3,10882,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10882,1,2,0)
 ;;=2^Ultrasound B Scan
 ;;^UTILITY(U,$J,358.3,10882,1,3,0)
 ;;=3^76512
 ;;^UTILITY(U,$J,358.3,10883,0)
 ;;=92235^^54^611^5^^^^1
 ;;^UTILITY(U,$J,358.3,10883,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10883,1,2,0)
 ;;=2^Fluorescein Angiography
 ;;^UTILITY(U,$J,358.3,10883,1,3,0)
 ;;=3^92235
 ;;^UTILITY(U,$J,358.3,10884,0)
 ;;=92240^^54^611^7^^^^1
 ;;^UTILITY(U,$J,358.3,10884,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10884,1,2,0)
 ;;=2^ICG Angiography
 ;;^UTILITY(U,$J,358.3,10884,1,3,0)
 ;;=3^92240
 ;;^UTILITY(U,$J,358.3,10885,0)
 ;;=67145^^54^611^9^^^^1
 ;;^UTILITY(U,$J,358.3,10885,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10885,1,2,0)
 ;;=2^Laser-Retinal Tear
 ;;^UTILITY(U,$J,358.3,10885,1,3,0)
 ;;=3^67145
 ;;^UTILITY(U,$J,358.3,10886,0)
 ;;=67220^^54^611^8^^^^1
 ;;^UTILITY(U,$J,358.3,10886,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10886,1,2,0)
 ;;=2^Laser-Choroidal Lesion
 ;;^UTILITY(U,$J,358.3,10886,1,3,0)
 ;;=3^67220
 ;;^UTILITY(U,$J,358.3,10887,0)
 ;;=67221^^54^611^10^^^^1
 ;;^UTILITY(U,$J,358.3,10887,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10887,1,2,0)
 ;;=2^Photodynamic Therapy
 ;;^UTILITY(U,$J,358.3,10887,1,3,0)
 ;;=3^67221
 ;;^UTILITY(U,$J,358.3,10888,0)
 ;;=67225^^54^611^11^^^^1
 ;;^UTILITY(U,$J,358.3,10888,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10888,1,2,0)
 ;;=2^Photodynamic Therapy,2nd Eye
 ;;^UTILITY(U,$J,358.3,10888,1,3,0)
 ;;=3^67225
 ;;^UTILITY(U,$J,358.3,10889,0)
 ;;=67141^^54^611^4^^^^1
 ;;^UTILITY(U,$J,358.3,10889,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10889,1,2,0)
 ;;=2^Cryotherapy-Retinal Tear
 ;;^UTILITY(U,$J,358.3,10889,1,3,0)
 ;;=3^67141
 ;;^UTILITY(U,$J,358.3,10890,0)
 ;;=67101^^54^611^3^^^^1
 ;;^UTILITY(U,$J,358.3,10890,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10890,1,2,0)
 ;;=2^Cryotherapy-Retinal Detachment
 ;;^UTILITY(U,$J,358.3,10890,1,3,0)
 ;;=3^67101
 ;;^UTILITY(U,$J,358.3,10891,0)
 ;;=67110^^54^611^12^^^^1
 ;;^UTILITY(U,$J,358.3,10891,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10891,1,2,0)
 ;;=2^Pneumatic Retinopexy
 ;;^UTILITY(U,$J,358.3,10891,1,3,0)
 ;;=3^67110
 ;;^UTILITY(U,$J,358.3,10892,0)
 ;;=92250^^54^611^6^^^^1
 ;;^UTILITY(U,$J,358.3,10892,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10892,1,2,0)
 ;;=2^Fundus Photography
 ;;^UTILITY(U,$J,358.3,10892,1,3,0)
 ;;=3^92250
 ;;^UTILITY(U,$J,358.3,10893,0)
 ;;=66030^^54^612^5^^^^1
 ;;^UTILITY(U,$J,358.3,10893,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10893,1,2,0)
 ;;=2^Inj Treatment of Eye,Medication
 ;;^UTILITY(U,$J,358.3,10893,1,3,0)
 ;;=3^66030
 ;;^UTILITY(U,$J,358.3,10894,0)
 ;;=67028^^54^612^6^^^^1
 ;;^UTILITY(U,$J,358.3,10894,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10894,1,2,0)
 ;;=2^Intravitreal Inj of Eye Drug
 ;;^UTILITY(U,$J,358.3,10894,1,3,0)
 ;;=3^67028
 ;;^UTILITY(U,$J,358.3,10895,0)
 ;;=67500^^54^612^10^^^^1
 ;;^UTILITY(U,$J,358.3,10895,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10895,1,2,0)
 ;;=2^Retrobulbar Inj,Medication
 ;;^UTILITY(U,$J,358.3,10895,1,3,0)
 ;;=3^67500
 ;;^UTILITY(U,$J,358.3,10896,0)
 ;;=67505^^54^612^9^^^^1
 ;;^UTILITY(U,$J,358.3,10896,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10896,1,2,0)
 ;;=2^Retrobulbar Inj,Alcohol
 ;;^UTILITY(U,$J,358.3,10896,1,3,0)
 ;;=3^67505
 ;;^UTILITY(U,$J,358.3,10897,0)
 ;;=68200^^54^612^13^^^^1
 ;;^UTILITY(U,$J,358.3,10897,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10897,1,2,0)
 ;;=2^Subconjunctival Injection
 ;;^UTILITY(U,$J,358.3,10897,1,3,0)
 ;;=3^68200
 ;;^UTILITY(U,$J,358.3,10898,0)
 ;;=96372^^54^612^11^^^^1
 ;;^UTILITY(U,$J,358.3,10898,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10898,1,2,0)
 ;;=2^SC/IM Injection
 ;;^UTILITY(U,$J,358.3,10898,1,3,0)
 ;;=3^96372
 ;;^UTILITY(U,$J,358.3,10899,0)
 ;;=96402^^54^612^12^^^^1
 ;;^UTILITY(U,$J,358.3,10899,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10899,1,2,0)
 ;;=2^SQ/IM Anti-Neplastic Hormone Inj
 ;;^UTILITY(U,$J,358.3,10899,1,3,0)
 ;;=3^96402
 ;;^UTILITY(U,$J,358.3,10900,0)
 ;;=C9257^^54^612^2^^^^1
 ;;^UTILITY(U,$J,358.3,10900,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10900,1,2,0)
 ;;=2^Bevacizumab Inj 0.25mg
 ;;^UTILITY(U,$J,358.3,10900,1,3,0)
 ;;=3^C9257
 ;;^UTILITY(U,$J,358.3,10901,0)
 ;;=J1094^^54^612^4^^^^1
 ;;^UTILITY(U,$J,358.3,10901,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10901,1,2,0)
 ;;=2^Dexamethasone Acetate Inj per 1mg
 ;;^UTILITY(U,$J,358.3,10901,1,3,0)
 ;;=3^J1094
 ;;^UTILITY(U,$J,358.3,10902,0)
 ;;=J2778^^54^612^8^^^^1
 ;;^UTILITY(U,$J,358.3,10902,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10902,1,2,0)
 ;;=2^Ranibizumab Inj per 0.1mg
 ;;^UTILITY(U,$J,358.3,10902,1,3,0)
 ;;=3^J2778
 ;;^UTILITY(U,$J,358.3,10903,0)
 ;;=J3300^^54^612^14^^^^1
 ;;^UTILITY(U,$J,358.3,10903,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10903,1,2,0)
 ;;=2^Triescence Inj per 1mg
 ;;^UTILITY(U,$J,358.3,10903,1,3,0)
 ;;=3^J3300
 ;;^UTILITY(U,$J,358.3,10904,0)
 ;;=J3301^^54^612^7^^^^1
 ;;^UTILITY(U,$J,358.3,10904,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10904,1,2,0)
 ;;=2^Kenalog Inj per 10mg
 ;;^UTILITY(U,$J,358.3,10904,1,3,0)
 ;;=3^J3301
 ;;^UTILITY(U,$J,358.3,10905,0)
 ;;=J3396^^54^612^15^^^^1
 ;;^UTILITY(U,$J,358.3,10905,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10905,1,2,0)
 ;;=2^Verteporfin Inj per 0.1mg
 ;;^UTILITY(U,$J,358.3,10905,1,3,0)
 ;;=3^J3396
 ;;^UTILITY(U,$J,358.3,10906,0)
 ;;=J9035^^54^612^3^^^^1
 ;;^UTILITY(U,$J,358.3,10906,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10906,1,2,0)
 ;;=2^Bevacizumab Inj 10mg
 ;;^UTILITY(U,$J,358.3,10906,1,3,0)
 ;;=3^J9035
 ;;^UTILITY(U,$J,358.3,10907,0)
 ;;=J0178^^54^612^1^^^^1
 ;;^UTILITY(U,$J,358.3,10907,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10907,1,2,0)
 ;;=2^Aflibercept Inj 1mg
 ;;^UTILITY(U,$J,358.3,10907,1,3,0)
 ;;=3^J0178
 ;;^UTILITY(U,$J,358.3,10908,0)
 ;;=67028^^54^613^1^^^^1
 ;;^UTILITY(U,$J,358.3,10908,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10908,1,2,0)
 ;;=2^Intravitreal Inj of Eye Drug
 ;;^UTILITY(U,$J,358.3,10908,1,3,0)
 ;;=3^67028
 ;;^UTILITY(U,$J,358.3,10909,0)
 ;;=J9035^^54^613^3^^^^1
 ;;^UTILITY(U,$J,358.3,10909,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10909,1,2,0)
 ;;=2^Bevacizumab Inj 10mg
 ;;^UTILITY(U,$J,358.3,10909,1,3,0)
 ;;=3^J9035
 ;;^UTILITY(U,$J,358.3,10910,0)
 ;;=J2778^^54^613^5^^^^1
 ;;^UTILITY(U,$J,358.3,10910,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10910,1,2,0)
 ;;=2^Ranibizumab Inj per 0.1mg
 ;;^UTILITY(U,$J,358.3,10910,1,3,0)
 ;;=3^J2778
 ;;^UTILITY(U,$J,358.3,10911,0)
 ;;=J3301^^54^613^4^^^^1
 ;;^UTILITY(U,$J,358.3,10911,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10911,1,2,0)
 ;;=2^Kenalog Inj per 10mg
 ;;^UTILITY(U,$J,358.3,10911,1,3,0)
 ;;=3^J3301
 ;;^UTILITY(U,$J,358.3,10912,0)
 ;;=J0178^^54^613^2^^^^1
 ;;^UTILITY(U,$J,358.3,10912,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10912,1,2,0)
 ;;=2^Aflibercept Inj 1mg
 ;;^UTILITY(U,$J,358.3,10912,1,3,0)
 ;;=3^J0178
 ;;^UTILITY(U,$J,358.3,10913,0)
 ;;=4450F^^54^614^2^^^^1
 ;;^UTILITY(U,$J,358.3,10913,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10913,1,2,0)
 ;;=2^Self-Care Ed Provided to Pt
 ;;^UTILITY(U,$J,358.3,10913,1,3,0)
 ;;=3^4450F
 ;;^UTILITY(U,$J,358.3,10914,0)
 ;;=4177F^^54^614^3^^^^1
 ;;^UTILITY(U,$J,358.3,10914,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10914,1,2,0)
 ;;=2^Talk Pt/Crgvr Re AREDS
 ;;^UTILITY(U,$J,358.3,10914,1,3,0)
 ;;=3^4177F
 ;;^UTILITY(U,$J,358.3,10915,0)
 ;;=4174F^^54^614^1^^^^1
 ;;^UTILITY(U,$J,358.3,10915,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10915,1,2,0)
 ;;=2^Couns Potent Glauc Impct
 ;;^UTILITY(U,$J,358.3,10915,1,3,0)
 ;;=3^4174F
 ;;^UTILITY(U,$J,358.3,10916,0)
 ;;=373.32^^55^615^48
 ;;^UTILITY(U,$J,358.3,10916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10916,1,3,0)
 ;;=3^Eyelid,Dermatitis,Allergic
 ;;^UTILITY(U,$J,358.3,10916,1,4,0)
 ;;=4^373.32
 ;;^UTILITY(U,$J,358.3,10916,2)
 ;;=^269061
 ;;^UTILITY(U,$J,358.3,10917,0)
 ;;=373.00^^55^615^4
 ;;^UTILITY(U,$J,358.3,10917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10917,1,3,0)
 ;;=3^Blepharitis
 ;;^UTILITY(U,$J,358.3,10917,1,4,0)
 ;;=4^373.00
 ;;^UTILITY(U,$J,358.3,10917,2)
 ;;=Blepharitis^15271
 ;;^UTILITY(U,$J,358.3,10918,0)
 ;;=373.2^^55^615^7
 ;;^UTILITY(U,$J,358.3,10918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10918,1,3,0)
 ;;=3^Chalazion
 ;;^UTILITY(U,$J,358.3,10918,1,4,0)
 ;;=4^373.2
 ;;^UTILITY(U,$J,358.3,10918,2)
 ;;=^22156
 ;;^UTILITY(U,$J,358.3,10919,0)
 ;;=374.84^^55^615^29
 ;;^UTILITY(U,$J,358.3,10919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10919,1,3,0)
 ;;=3^Eyelid Cysts
